(Interview) BrainsWay Aims to Treat COVID-Caused Depression by “Jumpstarting” Brain
In the media » (Interview) BrainsWay Aims to Treat COVID-Caused Depression by “Jumpstarting” Brain
BrainsWay CEO Christopher von Jako discusses how Deep TMS is used to treat neurological conditions such as depression and obsessive-compulsive disorder exacerbated by the coronavirus (Covid-19) pandemic.